Results 301 to 310 of about 390,951 (380)

Cancer treatment and survivorship statistics, 2025

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 4, Page 308-340, July/August 2025.
Abstract The number of people living with a history of cancer in the United States continues to rise because of the growth and aging of the population as well as improved survival through advances in early detection and treatment. To assist the public health community serve the needs of these survivors, the American Cancer Society and the National ...
Nikita Sandeep Wagle   +9 more
wiley   +1 more source

Activation of Genes by Nuclear Receptor/Specificity Protein (Sp) Interactions in Cancer. [PDF]

open access: yesCancers (Basel)
Safe S   +5 more
europepmc   +1 more source

Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease

open access: yesAlzheimer's &Dementia, Volume 21, Issue 7, July 2025.
Abstract INTRODUCTION Impaired mitochondrial function is seen in Alzheimer's disease (AD), but its role is unclear. Mitochondrial DNA (mtDNA) supports bioenergetic metabolism, but it is uncertain how it might influence AD neuropathology. METHODS We used cytoplasmic hybrid (cybrid) cell lines made from SH‐SY5Y cells expressing mtDNA from cognitively ...
Riley E. Kemna   +11 more
wiley   +1 more source

Metabolic Stress Expands Polyfunctional, Proinflammatory Th17 Cells in Patients With Psoriatic Arthritis for Whom There is Interleukin‐23–Independent Interleukin‐17 Production

open access: yesArthritis &Rheumatology, Volume 77, Issue 7, Page 842-853, July 2025.
Objective Genetic associations and blockade of the interleukin (IL)‐23/IL‐17 axis with monoclonal antibodies support a role for this pathway in patients with psoriatic arthritis (PsA). This study examines the requirement of IL‐23 for IL‐17 production and the role of the metabolic microenvironment in the expansion of Th17‐derived cells in patients with ...
Carmel B. Stober   +4 more
wiley   +1 more source

Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells. [PDF]

open access: yesFront Pharmacol
Yang Y   +11 more
europepmc   +1 more source

Measurable residual disease (MRD) as a surrogate end point for clinical drug approval in acute myeloid leukemia (AML): Perspectives from the MRD Partnership and Alliance in AML Clinical Treatment Consortium

open access: yesCancer, Volume 131, Issue 13, 1 July 2025.
Abstract Despite advances in acute myeloid leukemia (AML) treatment, significant unmet medical needs remain. Surrogate end points for overall survival can accelerate the approval of novel therapies. Measurable residual disease (MRD) is a promising surrogate end point candidate, providing a sensitive and quantitative assessment of disease burden ...
Michael Boyiadzis   +20 more
wiley   +1 more source

Vitamin A and its influence on tumour extracellular matrix. [PDF]

open access: yesDiscov Oncol
Xie G   +9 more
europepmc   +1 more source

Nail the diagnosis: Lamivudine-induced periungual pyogenic granulomas in PLHIV. [PDF]

open access: yesIDCases
Vaitheeswaran KK   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy